Biopolymeric self-assembled nanoparticles for enhanced antibacterial activity of Ag-based compounds

[Display omitted] Microbial infections still remain one of the main issues for human health. The rapid development of resistance towards the most common antimicrobial drugs in bacteria represents today a challenge in the infections management. In the present work we have investigated the antibacteri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 2017-01, Vol.517 (1-2), p.395-402
Hauptverfasser: Dhanyalayam, Dhanya, Scrivano, Luca, Parisi, Ortensia Ilaria, Sinicropi, Maria Stefania, Fazio, Antonietta, Saturnino, Carmela, Plutino, Maria Rosaria, Cristo, Francesca Di, Puoci, Francesco, Cappello, Anna Rita, Longo, Pasquale
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] Microbial infections still remain one of the main issues for human health. The rapid development of resistance towards the most common antimicrobial drugs in bacteria represents today a challenge in the infections management. In the present work we have investigated the antibacterial activity of a group of compounds, namely silver N-heterocyclic carbene complexes, against a broad spectrum of bacteria. For the most promising compound, a biopolymeric nanocarrier has been developed, in order to potentiate the metal complex activity against both Gram +ve and Gram −ve. The polymeric nanovehicle is based on dextran, modified with oleic acid residues, that confer amphiphilic properties to the polysaccharide. We have characterized the obtained biomaterial and studied its ability to self-assemble into nanoparticles in aqueous environment. Next, the transdermal diffusion analyses have been carried out to evaluate the ability of the polymeric particles to penetrate tissues. Thanks to the strategy adopted, we have fabricated an antibacterial system to which K. pneumoniae and E. coli are the most sensitive.
ISSN:0378-5173
1873-3476
DOI:10.1016/j.ijpharm.2016.12.039